Canopy Rivers Sets Filing Date for Q1 2021 Financial Results
– Canopy Rivers Inc. (“Canopy Rivers” or the “Company“) (TSX: RIV) (OTC: CNPOF) will report its first quarter fiscal year 2021 financial results before markets open on August …
Tag: investing in canadian cannabis companies
HEXO vapes now available across Canada
— HEXO Corp (“HEXO”, or the “Company”) (TSX: HEXO; NYSE: HEXO) is proud to launch its line of vape products to both adult-use and medical …
Indiva and Bhang Enter Amended License Agreement
— Indiva Limited (the “Company” or “Indiva”) (TSXV:NDVA) (OTCQX:NDVAF) is pleased to announce that it has entered into an amended license agreement (the “Amended License Agreement”) …
Organigram Reports Third Quarter Fiscal 2020 Results
Net revenue of $18.0 million compared to $24.8 million in Q3 2019 Generated positive cash flow from operations of $8.5 million as a result of …
WeedMD Reports First Quarter 2020 Financial Results and Posts Record Revenue of $12.2 Million
Net revenue of $12.2 million, a 327% sequential increase, driven by strong growth from adult-use and medical channels and substantial outdoor biomass sale Strengthens balance …
The Valens Company Announces Participation in First-of-its-Kind Real-World Evidence Study on Medical Cannabis Led by the University Health Network in Partnership with Shoppers Drug Mart
–The Valens Company Inc. (TSX: VLNS) (OTCQX: VLNCF) (the “Company” or “The Valens Company“), a global leader in the end-to-end development and manufacturing of innovative, cannabinoid-based products, today announced …